These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21418334)

  • 1. Effect of psoriasis therapy on VEGF and its soluble receptors serum concentrations.
    Flisiak I; Zaniewski P; Rogalska-Taranta M; Chodynicka B
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):302-7. PubMed ID: 21418334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of psoriasis activity on VEGF and its soluble receptors concentrations in serum and plaque scales.
    Flisiak I; Zaniewski P; Rogalska M; Myśliwiec H; Jaroszewicz J; Chodynicka B
    Cytokine; 2010 Dec; 52(3):225-9. PubMed ID: 20980160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor in psoriasis: an indicator of disease severity and control.
    Nofal A; Al-Makhzangy I; Attwa E; Nassar A; Abdalmoati A
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):803-6. PubMed ID: 19309427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Circulating VEGF and its soluble receptor sVEGFR-1 in patients with lung cancer].
    Swidzińska E; Ossolińska M; Naumnik W; Izycki T; Kucejko W; Chyczewska E
    Pneumonol Alergol Pol; 2004; 72(9-10):389-94. PubMed ID: 16021992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating vascular endothelial growth factor and its soluble receptors in patients with liver cirrhosis: possible association with hepatic function impairment.
    Jaroszewicz J; Januszkiewicz M; Flisiak R; Rogalska M; Kalinowska A; Wierzbicka I
    Cytokine; 2008 Oct; 44(1):14-7. PubMed ID: 18656381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum vascular endothelial growth factor and its receptor level in patients with chronic obstructive pulmonary disease.
    Kierszniewska-Stepień D; Pietras T; Górski P; Stepien H
    Eur Cytokine Netw; 2006 Mar; 17(1):75-9. PubMed ID: 16613766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian hyperstimulation syndrome is correlated with a reduction of soluble VEGF receptor protein level and a higher amount of VEGF-A.
    Pietrowski D; Szabo L; Sator M; Just A; Egarter C
    Hum Reprod; 2012 Jan; 27(1):196-9. PubMed ID: 22016416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenic activity in patients with psoriasis is significantly decreased by Goeckerman's therapy.
    Andrys C; Borska L; Pohl D; Fiala Z; Hamakova K; Krejsek J
    Arch Dermatol Res; 2007 Mar; 298(10):479-83. PubMed ID: 17221216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma.
    Yu XM; Lo CY; Lam AK; Lang BH; Leung P; Luk JM
    Surgery; 2008 Dec; 144(6):934-40; discussion 940-1. PubMed ID: 19041000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of open versus laparoscopically assisted colectomy on soluble vascular endothelial growth factor (sVEGF) and its soluble receptor 1 (sVEGFR1).
    Svendsen MN; Werther K; Christensen IJ; Basse L; Nielsen HJ
    Inflamm Res; 2005 Nov; 54(11):458-63. PubMed ID: 16307219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.
    Yu XM; Lo CY; Lam AK; Leung P; Luk JM
    Ann Surg; 2008 Mar; 247(3):483-9. PubMed ID: 18376194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study.
    Boehncke S; Salgo R; Garbaraviciene J; Beschmann H; Hardt K; Diehl S; Fichtlscherer S; Thaçi D; Boehncke WH
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1187-93. PubMed ID: 21241371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of psoriasis activity on epidermal growth factor (EGF) and the concentration of soluble EGF receptor in serum and plaque scales.
    Flisiak I; Szterling-Jaworowska M; Baran A; Rogalska-Taranta M
    Clin Exp Dermatol; 2014 Jun; 39(4):461-7. PubMed ID: 24825137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of psoriasis treatment on plasma concentrations of metalloproteinase-1 and tissue inhibitor of metalloproteinases-1.
    Flisiak I; Myśliwiec H; Chodynicka B
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):418-21. PubMed ID: 15987285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Soluble tumor-necrosis-factor-alpha receptor type-1 as a marker of activity of psoriasis vulgaris and effects of its treatment].
    Serwin AB; Sokołowska M; Chodynicka B
    Przegl Lek; 2005; 62(2):95-7. PubMed ID: 16095152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selenium supplementation, soluble tumor necrosis factor-alpha receptor type 1, and C-reactive protein during psoriasis therapy with narrowband ultraviolet B.
    Serwin AB; Wasowicz W; Chodynicka B
    Nutrition; 2006 Sep; 22(9):860-4. PubMed ID: 16829029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum interleukin-22 and vascular endothelial growth factor serve as sensitive biomarkers but not as predictors of therapeutic response to biologics in patients with psoriasis.
    Shimauchi T; Hirakawa S; Suzuki T; Yasuma A; Majima Y; Tatsuno K; Yagi H; Ito T; Tokura Y
    J Dermatol; 2013 Oct; 40(10):805-12. PubMed ID: 23915382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group.
    Werther K; Christensen IJ; Brünner N; Nielsen HJ
    Eur J Surg Oncol; 2000 Nov; 26(7):657-62. PubMed ID: 11078612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble VEGF/sFLt1 ratio is an independent predictor of AML patient out come.
    Aref S; El Sherbiny M; Goda T; Fouda M; Al Askalany H; Abdalla D
    Hematology; 2005 Apr; 10(2):131-4. PubMed ID: 16019458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma VEGF-A and its soluble receptor R1 correlate with the clinical stage of colorectal cancer.
    Myśliwiec P; Piotrowski Z; Zalewski B; Kukliński A; Pawlak K
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():85-7. PubMed ID: 15638384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.